Skip to main content
Premium Trial:

Request an Annual Quote

GSK Licenses Jubilant s Pathway Database

NEW YORK, Jan. 25 (GenomeWeb News) - Glaxo SmithKline has licensed Jubilant Biosys' pathway database, Jubilant of Bangalore, India, said today.

 

Under the global license, Glaxo plans to use the database, PathArt, for its drug discovery research.

 

PathArt contains more than 1,200 signal-, metabolic-, and disease-specific pathways that have been manually curated. These pathways cover a number of diseases, including different types of cancer, arthritis, Alzheimer's disease, asthma, multiple sclerosis, Parkinson's disease, diabetes, and atherosclerosis.

The Scan

Comfort of Home

The Guardian reports that AstraZeneca is to run more clinical trials from people's homes with the aim of increasing participant diversity.

Keep Under Control

Genetic technologies are among the tools suggested to manage invasive species and feral animals in Australia, Newsweek says.

Just Make It

The New York Times writes that there is increased interest in applying gene synthesis to even more applications.

Nucleic Acids Research Papers on OncoDB, mBodyMap, Genomicus

In Nucleic Acids Research this week: database to analyze large cancer datasets, human body microbe database, and more.